Supplementary Figure S11 and Tables S1-S3

Total Page:16

File Type:pdf, Size:1020Kb

Supplementary Figure S11 and Tables S1-S3 Supplementary Figure S11: Regulation of an embryonic Wnt-interactive network by SYT-SSX2 and in human synovial sarcomas Genes in black letters represent SYT-SSX2 transcriptional targets in the C2C12 myoblasts, genes in red letters and red underline are the SYT-SSX2 targets in human mesenchymal stem cells, genes in green letters and green asterisks were identified in the transcriptomes of two human synovial sarcoma arrays (Supplementary Tables S1-S3). Names in italics signify downregulated genes. The upper left columns list components of the Wnt pathway found in the four arrays. The lower left columns are mediators of the developmental pathways that interact with Wnt to drive embryogenesis. The right panel displays controllers of embryonic patterning and morphogenesis. Supplementary Table S1: Differentially regulated Wnt components in mesenchymal precursor cells expressing SYT-SSX2 and in synovial sarcoma tumors Symbol Name Accession C2C12 hMSCs SS tumors WNT 4 WNT 4 Wingless-related MMTV integration site 4 NM_030761 WNT 5a 1 Wingless-related MMTV integration site 5a NM_003392 WNT 6 1 Wingless-related MMTV integration site 6 NM_006522 WNT 7a Wingless-related MMTV integration site 7a NM_009527 WNT 7b WNT 7b Wingless-related MMTV integration site 7b NM_058238 WNT 11 WNT 11 Wingless-related MMTV integration site 11 NM_004626 WNT 2 1 Wingless-related MMTV integration site 2 NM_003391 FZD 1 FZD 1 1, 2 Frizzled homolog 1 NM_021457 FZD 2 FZD 2 Frizzled homolog 2 NM_001466 FZD 3 FZD 3 Frizzled homolog 3 NM_017412 FZD 6 1, 2 Frizzled homolog 6 NM_003506 FZD 7 1, 2 Frizzled homolog 7 NM_003507 FZD 8 1, 2 Frizzled homolog 8 NM_031866 LRP 1 1, 2 Low density lipoprotein receptor-related protein 1 NM_002332 LRP 4 Low density lipoprotein receptor-related protein 4 NM_172668 LRP 5 LRP 5 1 Low density lipoprotein receptor-related protein 5 NM_002335 LRP 8 1, 2 Low density lipoprotein receptor-related protein 8 NM_004631 LEF 1 LEF 1 1, 2 Lymphoid enhancer factor binding 1 NM_016269 TCF 7L2 1, 2 Transcription factor 7-like 2 NM_030756 TCF 7L1 1, 2 Transcription factor 7-like 1 NM_003200 TCF 7 TCF 7 2 Transcription factor 7 NM_003202 CCDC88C DVL associating protein with a high frequency of leucine NM_001080414 AXIN 2 AXIN 2 AXIN 2 2 Axin 2 NM_004655 FRZB FRZB 1 Frizzled related protein NM_001463 SFRP 1 SFRP 1 2 Secreted frizzled-related protein 1 NM_003012 SFRP 4 1, 2 Secreted frizzled-related protein 4 NM_003014 DKK 3 DKK3 2 Dickkopf homolog 3 NM_015814 KREMEN 1 Kringle containing transmembrane protein 1 NM_001039570 DACT 1 DACT 1 Dapper homolog 1 NM_016651 ROR 2 ROR 2 1 Receptor tyrosine kinase-like orphan receptor 2 NM_004560 RYK Receptor-like tyrosine kinase NM_013649 APCDD1 APCDD1 Adenomatous polyposis coli down-regulated 1 NM_153000 TLE 1 Transducin-like enhancer 1 NM_005077 TLE 2 TLE 2 1, 2 Transducin-like enhancer 2 NM_003260 TLE 3 TLE 3 TLE 3 2 Transducin-like enhancer 3 NM_005078 TLE4 TLE 4 1, 2 Transducin-like enhancer 4 NM_007005 RSPO 1 R-spondin homolog 1 NM_001038633 RSPO 2 R-spondin homolog 2 NM_178565 DAB 2 DAB 2 DAB 2 2 Disabled homolog 2 NM_001343 PPP2R2C PPP2R2C PPP2R2C 2 Protein phosphatase 2, regulatory subunit b, gamma NM_020416 Underlined genes are downregulated . A partial list was published in Garcia et al., 2012a. Supplementary Table S2. Differentially regulated Wnt targets in mesenchymal precursor cells (4 pages) expressing SYT-SSX2 and in synovial sarcoma tumors Symbol Gene Name Accession C2C12 hMSCs SS tumors CCND 1 CCND 1 1, 2 Cyclin D1 NM_053056 CCND 2 CCND 2 CCND 2 1, 2 Cyclin D2 NM_001759 MYC MYC MYC 1, 2 Myelocytomatosis oncogene NM_002467 WNT 11 WNT 11 Wingless-related MMTV integration site 11 NM_004626 AXIN 2 AXIN 2 AXIN 2 2 Axin 2 NM_004655 LGR 5 LGR 5 LGR 5 1 Leucine rich repeat G protein coupled receptor 5 NM_003667 JUN 1, 2 JUN proto-oncogene NM_005354 MMP 2 Matrix metallopeptidase 2 NM_008610 MMP 9 Matrix metallopeptidase 9 NM_013599 MMP 10 MMP 10 MMP 10 2 Matrix metallopeptidase 10 NM_002425 MMP 11 Matrix metallopeptidase 11 NM_008606 MMP 13 Matrix metallopeptidase 13 NM_008607 MMP 14 Matrix metallopeptidase 14 NM_008608 MMP 15 MMP 15 MMP 15 1, 2 Matrix metallopeptidase 15 NM_002428 MMP 16 Matrix metallopeptidase 16 NM_019724 MMP 19 MMP19 MMP19 2 Matrix metallopeptidase 19 NM_002429 EPH A2 Eph receptor A2 NM_010139 EPH A3 Eph receptor A3 NM_005233 EPH A4 EPH A4 EPH A4 2 Eph receptor A4 NM_004438 EPH A8 Eph receptor A8 NM_007939 EPH B1 EPH B1 EPH B1 1 Eph receptor B1 NM_004441 EPH B2 EPH B2 2 Eph receptor B2 NM_004442 EPH B3 EPH B3 EPH B3 1 Eph receptor B3 NM_004443 EPH B4 EPH B4 2 Eph receptor B4 NM_004444 EPH B6 EPH B6 EPH B6 2 Eph receptor B6 NM_004446 EFN A1 EFN A1 1, 2 Ephrin A1 NM_004428 EFN A3 EFN A3 Ephrin A3 NM_004952 EFN A4 EFN A4 2 Ephrin A4 NM_005227 EFN A5 Ephrin A5 NM_001962 EFN B1 EFN B1 Ephrin B1 NM_004429 EFN B2 1 Ephrin B2 NM_004093 LIF Leukemia inhibitory factor NM_008501 LBH LBH Limb bud heart NM_030915 ID 1 Inhibitor of DNA binding 1 NM_181353 ID 2 ID 2 1, 2 Inhibitor of DNA binding 2 NM_002166 ID 3 ID 3 1 Inhibitor of DNA binding 3 NM_002167 ID 4 ID 4 1, 2 Inhibitor of DNA binding 4 NM_001546 IGF2 IGF2 IGF2 1, 2 Insulin-like growth factor 2 NM_000612 IGFBP2 IGFBP2 IGFBP2 1, 2 Insulin-like growth factor binding protein 2 NM_000597 SHH SHH Sonic hedgehog homolog NM_000193 GLI 2 GLI 2 1 Glioma-associated oncogene family zinc finger 2 NM_005270 DLL 1 DLL 1 DLL 1 1, 2 Delta-like 1 NM_005618 JAG 1 JAG 1 2 Jagged 1 NM_000214 JAG 2 JAG 2 1 Jagged 2 NM_002226 NOTCH 1 NOTCH 1 2 NOTCH (Drosophila) homolog 1 NM_017617 HES 1 HES 1 Hairy and enhancer of split 1 NM_005524 FGF2 FGF 2 1, 2 Fibroblast growth factor 2 NM_002006 FGF7 FGF 7 1, 2 Fibroblast growth factor 7 NM_002009 FGF 9 FGF 9 Fibroblast growth factor 9 NM_002010 FGF 18 FGF 18 1, 2 Fibroblast growth factor 18 NM_003862 FGF 19 Fibroblast growth factor 19 NM_005117 TGFB 3 Transforming growth factor beta 3 NM_009368 NOG Noggin NM_005450 RET RET RET proto-oncogene NM_020975 GDNF 1 Glial cell-derived neurotrophic factor NM_010275 MITF 1, 2 Microphthalmia-associated transcription factor NM_198159 SOX 9 SOX 9 1, 2 SRY-related HMG-box 9 NM_000346 SOX 4 1 SRY-related HMG-box 4 NM_003107 SOX 3 1 SRY-related HMG-box 3 NM_005634 SOX 17 SRY-related HMG-box 17 NM_022454 PROX 1 PROX 1 Prospero homeobox 1 NM_002763 RUNX2 1 Runt-related transcription factor 2 NM_001024630 DLX 3 DLX 3 Distal-less homeobox 3 NM_005220 DLX 4 1 Distal-less homeobox 4 NM_138281 DLX 5 DLX 5 1 Distal-less homeobox 5 NM_005221 MSX 1 Msh homeobox 1 NM_010835 MSX 2 1, 2 Msh homeobox 2 NM_002449 FOX C2 Forkhead box protein C2 NM_013519 FOX C1 FOX C1 1, 2 Forkhead box protein C1 NM_001453 FOX D1 FOX D1 2 Forkhead box protein D1 NM_008242 FOX G1B 1 Forkhead box protein G1B NM_005249 FOX M1 Forkhead box protein M1 NM_202002 HOX B6 HOX B6 Homeobox B6 NM_018952 HOX B8 Homeobox B8 NM_010461 HOX B9 HOX B9 Homeobox B9 NM_024017 PAX 9 Paired box 9 NM_011041 BMP 4 BMP 4 1, 2 Bone morphogenetic protein 4 NM_001202 RARG RARG 1, 2 Retinoic acid receptor gamma NM_000966 RSPO 1 R-spondin homolog 1 NM_001038633 RSPO 2 R-spondin homolog 2 NM_178565 HMGA 1 High mobility group AT-hook 1 NM_001025427 HMGA2 HMGA 1 2 High mobility group AT-hook 2 NM_010441 GBX2 Gastrulation brain homeobox 2 NM_001485 NEUROD1 Neurogenic differentiation 1 NM_002500 NEUROG3 Neurogenin 3 NM_020999 NKX2-2 NK2 homeobox 2 NM_002509 SIX 1 SIX 1 Sine oculis-related homeobox 1 NM_009189 ZCCHC12 ZCCHC12 Zinc finger CCHC domain containing 12 NM_173798 ODZ3 Odz odd Oz/ten-m homolog 3 NM_011857 ETS2 Erythroblastosis virus E26 oncogen homolog 2e NM_005239 PBX 3 1, 2 Pre-B- cell leukemia homeobox 3 NM_006195 ZEB 1 Zinc finger E-box binding homeobox 1 NM_011546 SNAI 2 SNAI 2 1, 2 Snail homolog 2 NM_011415 THBS 1 THBS 1 1, 2 Thrombospondin 1 NM_003246 THBS 2 THBS 2 1, 2 Thrombospondin 2 NM_003247 THBS 3 THBS 3 2 Thrombospondin 3 NM_007112 THBS 4 1 Thrombospondin 4 NM_003248 BIRC 5 BIRC 5 2 Survivin NM_001168 ENPP1 ENPP 1 ENPP1 1, 2 Ectonucleotide pyrophosphatase/phosphodiesterase 1 NM_006208 ENPP 2 ENPP2 2 Ectonucleotide pyrophosphatase/phosphodiesterase 2 NM_006209 ENPP 3 Ectonucleotide pyrophosphatase/phosphodiesterase 3 NM_134005 EGFR EGFR 1 Epidermal growth factor receptor NM_005228 MET MET 2 Hepatocyte growth factor receptor NM_001127500 VDR Vitamin D (1,25- dihydroxyvitamin D3) receptor NM_009504 NRP 1 Neuropilin 1 NM_008737 NRP 2 NRP 2 1, 2 Neuropilin 2 NM_201266 MAPT MAPT 1 Microtubule associated protein Tau NM_016835 STRA 6 STRA 6 Stimulated by retinoic acid gene 6 NM_022369 VEGFC VEGFC 2 Vascular endothelial growth factor C NM_005429 PLAU PLAU 1, 2 Plasminogen activator urokinase NM_002658 PLAUR PLAUR 1, 2 Plasminogen activator urokinase receptor NM_002659 TNC Tenascin C NM_002160 FST Follistatin NM_006350 POSTN POSTN POSTN 2 Periostin NM_006475 PTN PTN 1 Pleiotrophin NM_002825 PTTG 1 PTTG 1 2 Pituitary tumor-transforming 1 NM_004219 CLU CLU CLU 2 Clusterin NM_001831 CALML 4 Calmodulin-like 4 NM_138304 VCAN VCAN 2 Versican NM_001081249 ANGPTL 4 Angiopoietin-like 4 NM_020581 UNC 5B UNC 5B 2 Unc-5 homolog b (C.elegans) NM_170744 SEMA 3A SEMA 3A SEMA 3A 2 Semaphorin 3A NM_006080 LAMC 2 1 Laminin gamma 2 NM_005562 FN 1 FN 1 Fibronectin 1 NM_212482 C3 C3 Complement component 3 NM_000064 IL8 Interleukin 8 NM_000584 IL6 1 Interleukin 6 NM_000600 NRCAM NRCAM NRCAM 1 Neuronal cell adhesion molecule NM_001037132 L1CAM L1CAM L1 cell adhesion molecule NM_000425 RHOU RHOU Ras homolog gene family member U NM_021205 Immunoglobulin superfamily containing leucine rich ISLR repeats NM_012043 EDN1 1 Endothelin 1 NM_001955 CD44 1, 2 CD44 molecule
Recommended publications
  • Deciphering the Functions of Ets2, Pten and P53 in Stromal Fibroblasts in Multiple
    Deciphering the Functions of Ets2, Pten and p53 in Stromal Fibroblasts in Multiple Breast Cancer Models DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Julie Wallace Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2013 Dissertation Committee: Michael C. Ostrowski, PhD, Advisor Gustavo Leone, PhD Denis Guttridge, PhD Dawn Chandler, PhD Copyright by Julie Wallace 2013 Abstract Breast cancer is the second most common cancer in American women, and is also the second leading cause of cancer death in women. It is estimated that nearly a quarter of a million new cases of invasive breast cancer will be diagnosed in women in the United States this year, and approximately 40,000 of these women will die from breast cancer. Although death rates have been on the decline for the past decade, there is still much we need to learn about this disease to improve prevention, detection and treatment strategies. The majority of early studies have focused on the malignant tumor cells themselves, and much has been learned concerning mutations, amplifications and other genetic and epigenetic alterations of these cells. However more recent work has acknowledged the strong influence of tumor stroma on the initiation, progression and recurrence of cancer. Under normal conditions this stroma has been shown to have protective effects against tumorigenesis, however the transformation of tumor cells manipulates this surrounding environment to actually promote malignancy. Fibroblasts in particular make up a significant portion of this stroma, and have been shown to impact various aspects of tumor cell biology.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,109,232 B2 Schwartz Et Al
    US009 109232B2 (12) United States Patent (10) Patent No.: US 9,109,232 B2 Schwartz et al. (45) Date of Patent: Aug. 18, 2015 (54) ETS2 AND MESP1 GENERATE CARDIAC Islas et al., Transcription factors ETS2 and MESP1 transdifferentiate PROGENITORS FROM FIBROBLASTS human dermal fibroblasts into cardiac progenitors; PNAS, Published online before print Jul. 23, 2012, doi: 10.1073/pnas. 11202991.09, 2012.* (71) Applicants: University of Houston, Houston, TX Melotti et al., Ets-2 and c-Myb Act Independently in Regulating (US); Texas Heart Institute, Houston, Expression of the Hematopoietic StemCell Antigen CD34:JBC, vol. TX (US); The Texas A&M University 269, No. 41, pp. 25303-25309, 1994.* System, College Station, TX (US) Takahashi et al., Induction of pluripotent stem cells from adulthuman fibroblasts by defined factors; Cell, vol. 131, pp. 861-872, 2007.* Naldini et al. In vivo gene delivery and stable transduction of (72) Inventors: Robert J. Schwartz, Houston, TX (US); nondividing cells by a lentiviral vector; Science, vol. 272, pp. 263 Vladimir N. Potaman, Houston, TX 267, 1996.* (US); Jose Francisco Islas, Houston, TX European Patent Office; Office Action; European Application No. (US) 117114082; Jul 22, 2013. European Patent Office; Response to Office Action; European Appli (73) Assignees: University of Houston, Houston, TX cation No. 11711408.2; Aug. 30, 2013. Chinese Patent Office; Office Action; Chinese Patent Application No. (US); Texas Heart Institute, Houston, 2011800 19561.0; Sep. 18, 2013. TX (US); The Texas A&M University Chinese Patent Office; Office Action (English translation); Chinese System, College Station, TX (US) Patent Application No. 2011800 19561.0; Sep.
    [Show full text]
  • Ephrin-A4/Fc Chimera Human
    EPHRIN-A4 EXTRACELLULAR DOMAIN/FC CHIMERA Human, Recombinant Expressed in NSO mouse myeloma cells Product Number E 0403 Storage Temperature –20 °C Synonyms: LERK-4; EFL-4 Reagents Recombinant human Ephrin-A4 extracellular domain/Fc Product Description chimera is supplied as approximately 200 mg of protein Recombinant human Ephrin-A4 extracellular domain/Fc lyophilized from a sterile-filtered phosphate-buffered chimera consists of amino acid residues 1-171 saline (PBS) solution. 1 (extracellular domain of human Ephrin-A4) that was fused by means of a polypeptide linker to the Fc portion Preparation Instructions of human IgG1 that is 6X histidine-tagged at the Reconstitute the vial contents with sterile PBS. carboxyl terminus. The chimeric protein is expressed in Stock solution concentration should be no less than a mouse myeloma cell line, NSO. Recombinant Ephrin 100 µg/ml. A4 is a disulfide-linked homodimer. The amino terminus is Leu 26 determined by N-terminal Storage/Stability sequencing. The calculated molecular mass of the Lyophilized samples are stable for greater than six reduced protein is approximately 43.7 kDa, but as a months at –20 °C. Upon reconstitution, store at 2-4 °C result of glycosylation, the recombinant Ephrin-A4/Fc for up to one month. For extended storage, store in migrates as an approximately 50 kDa protein on working aliquots at –20 °C. Repeated freeze-thaw reducing SDS -PAGE. cycles should be avoided. Do not store in frost-free freezer. The Ephrin ligand family, of which Ephrin-A4 is a member, binds members of the Eph receptor family. All Product Profile ligands share a conserved extracellular sequence, Identity of Ephrin-A4/Fc was determined by western thought to correspond to the receptor binding domain.
    [Show full text]
  • Epha Receptors and Ephrin-A Ligands Are Upregulated by Monocytic
    Mukai et al. BMC Cell Biology (2017) 18:28 DOI 10.1186/s12860-017-0144-x RESEARCHARTICLE Open Access EphA receptors and ephrin-A ligands are upregulated by monocytic differentiation/ maturation and promote cell adhesion and protrusion formation in HL60 monocytes Midori Mukai, Norihiko Suruga, Noritaka Saeki and Kazushige Ogawa* Abstract Background: Eph signaling is known to induce contrasting cell behaviors such as promoting and inhibiting cell adhesion/ spreading by altering F-actin organization and influencing integrin activities. We have previously demonstrated that EphA2 stimulation by ephrin-A1 promotes cell adhesion through interaction with integrins and integrin ligands in two monocyte/ macrophage cell lines. Although mature mononuclear leukocytes express several members of the EphA/ephrin-A subclass, their expression has not been examined in monocytes undergoing during differentiation and maturation. Results: Using RT-PCR, we have shown that EphA2, ephrin-A1, and ephrin-A2 expression was upregulated in murine bone marrow mononuclear cells during monocyte maturation. Moreover, EphA2 and EphA4 expression was induced, and ephrin-A4 expression was upregulated, in a human promyelocytic leukemia cell line, HL60, along with monocyte differentiation toward the classical CD14++CD16− monocyte subset. Using RT-PCR and flow cytometry, we have also shown that expression levels of αL, αM, αX, and β2 integrin subunits were upregulated in HL60 cells along with monocyte differentiation while those of α4, α5, α6, and β1 subunits were unchanged. Using a cell attachment stripe assay, we have shown that stimulation by EphA as well as ephrin-A, likely promoted adhesion to an integrin ligand- coated surface in HL60 monocytes. Moreover, EphA and ephrin-A stimulation likely promoted the formation of protrusions in HL60 monocytes.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Targeting the Tryptophan Hydroxylase 2 Gene for Functional Analysis in Mice and Serotonergic Differentiation of Embryonic Stem Cells
    TARGETING THE TRYPTOPHAN HYDROXYLASE 2 GENE FOR FUNCTIONAL ANALYSIS IN MICE AND SEROTONERGIC DIFFERENTIATION OF EMBRYONIC STEM CELLS Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) submitted to the Department of Biology, Chemistry and Pharmacy of Freie Universität Berlin by Dana Kikic, M.Sc. in Molecular biology and Physiology from Nis June, 2009 The doctorate studies were performed in the research group of Prof. Michael Bader Molecular Biology of Peptide Hormones at Max-Delbrück-Center for Molecular Medicine in Berlin, Buch Mai 2005 - September 2008. 1st Reviewer: Prof. Michael Bader 2nd Reviewer: Prof. Udo Heinemann date of defence: 13. August 2009 ACKNOWLEDGMENTS Herewith, I would like to acknowledge the persons who made this thesis possible and without whom my initiation in the world of basic science research would not have the spin it has now, neither would my scientific illiteracy get the chance to eradicate. I am expressing my very personal gratitude and recognition to: Prof. Michael Bader, for an inexhaustible guidance in all the matters arising during the course of scientific work, for an instinct in defining and following the intellectual challenge and for letting me following my own, for necessary financial support, for defining the borders of reasonable and unreasonable, for an invaluable time and patience, and an amazing efficiency in supporting, motivating, reading, correcting and shaping my scientific language during the last four years. Prof. Harald Saumweber and Prof. Udo Heinemann, for taking over the academic supervision of the thesis, and for breathing in it a life outside the laboratory walls and their personal signature.
    [Show full text]
  • Supp Table 1.Pdf
    Upregulated genes in Hdac8 null cranial neural crest cells fold change Gene Symbol Gene Title 134.39 Stmn4 stathmin-like 4 46.05 Lhx1 LIM homeobox protein 1 31.45 Lect2 leukocyte cell-derived chemotaxin 2 31.09 Zfp108 zinc finger protein 108 27.74 0710007G10Rik RIKEN cDNA 0710007G10 gene 26.31 1700019O17Rik RIKEN cDNA 1700019O17 gene 25.72 Cyb561 Cytochrome b-561 25.35 Tsc22d1 TSC22 domain family, member 1 25.27 4921513I08Rik RIKEN cDNA 4921513I08 gene 24.58 Ofa oncofetal antigen 24.47 B230112I24Rik RIKEN cDNA B230112I24 gene 23.86 Uty ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome 22.84 D8Ertd268e DNA segment, Chr 8, ERATO Doi 268, expressed 19.78 Dag1 Dystroglycan 1 19.74 Pkn1 protein kinase N1 18.64 Cts8 cathepsin 8 18.23 1500012D20Rik RIKEN cDNA 1500012D20 gene 18.09 Slc43a2 solute carrier family 43, member 2 17.17 Pcm1 Pericentriolar material 1 17.17 Prg2 proteoglycan 2, bone marrow 17.11 LOC671579 hypothetical protein LOC671579 17.11 Slco1a5 solute carrier organic anion transporter family, member 1a5 17.02 Fbxl7 F-box and leucine-rich repeat protein 7 17.02 Kcns2 K+ voltage-gated channel, subfamily S, 2 16.93 AW493845 Expressed sequence AW493845 16.12 1600014K23Rik RIKEN cDNA 1600014K23 gene 15.71 Cst8 cystatin 8 (cystatin-related epididymal spermatogenic) 15.68 4922502D21Rik RIKEN cDNA 4922502D21 gene 15.32 2810011L19Rik RIKEN cDNA 2810011L19 gene 15.08 Btbd9 BTB (POZ) domain containing 9 14.77 Hoxa11os homeo box A11, opposite strand transcript 14.74 Obp1a odorant binding protein Ia 14.72 ORF28 open reading
    [Show full text]
  • Role of the Wnt/ B-Catenin Pathway in Liver Development and Zonation
    University of Bath PHD Role of the Wnt/ -catenin Pathway in Liver Development and Zonation Shen Wen, Yeh Award date: 2012 Awarding institution: University of Bath Link to publication Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 10. Oct. 2021 Role of the Wnt/ -catenin Pathway in Liver Development and Zonation YEH, SHENG-WEN A thesis submitted for the degree of Doctor of Philosophy University of Bath Department of Biology and Biochemistry September, 2012 COPYRIGHT Attention is drawn to the fact that copyright of this thesis rests with the author. A copy of this thesis has been supplied on condition that anyone who consults it is understood to recognise that its copyright rests with the author and that they must not copy it or use material from it except as permitted by law or with the consent of the author.
    [Show full text]
  • Anti-Human EPHA4 / EPH Receptor A4 (Internal) Polyclonal Antibody
    For Research Use Only. REV: 9/9/2014 Anti-Human EPHA4 / EPH Receptor A4 (Internal) Polyclonal Antibody CatalogID MC-2841 Target Protein EPH receptor A4 (EPHA4) Synonyms EPHA4 Antibody, CEK8 Antibody, EK8 Antibody, Ephrin type-A receptor 4 Antibody, HEK8 Antibody, SEK Antibody, TYRO1 Antibody, TYRO1 protein tyrosine kinase Antibody, Tyrosine-protein kinase TYRO1 Antibody, EPH receptor A4 Antibody, EPH-like kinase 8 Antibody Family / Subfamily Protein Kinase / Ephrin Receptor Host EPHA4 antibody was produced in Rabbit Clonality Polyclonal Immunogen Species EPHA4 / EPH Receptor A4 antibody was raised against Human Antigen Type Synthetic peptide Immunogen EPHA4 / EPH Receptor A4 antibody was raised against synthetic 18 amino acid peptide from internal region of human EPHA4. Percent identity with other species by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Marmoset, Panda, Bovine, Dog, Bat, Horse, Pig (100%); Mouse, Rat, Hamster, Elephant, Rabbit, Opossum, Platypus, Xenopus (94%); Turkey, Chicken (89%); Lizard (83%). Specificity Human EPHA4. BLAST analysis of the peptide immunogen showed no homology with other human proteins. Epitope Internal Reactivity Human (human tissues have been tested in IHC with FFPE) Predicted Reactivity Gorilla, Gibbon, Monkey, Bat, Bovine, Dog, Horse, Pig, Mouse, Rat, Hamster, Rabbit, Xenopus Purification Immunoaffinity purified Presentation PBS, 0.1% sodium azide. Recommended Storage Long term: -70°C; Short term: +4°C Uses IHC - Paraffin (3 μg/ml) (Optimal dilution to be determined by the researcher) Size 50 µg Concentration 1 mg/ml For research use only. Not intended for human, diagnostic, therapeutic, or drug use. Immunohistochemistry Anti-EPHA4 antibody MC-2841 IHC of human kidney, glomerulus. Immunohistochemistry of formalin-fixed, paraffin- embedded tissue after heat-induced antigen retrieval.
    [Show full text]
  • Epha3 Inhibits Migration and Invasion of Esophageal Cancer Cells by Activating the Mesenchymal‑Epithelial Transition Process
    722 INTERNATIONAL JOURNAL OF ONCOLOGY 54: 722-732, 2019 EphA3 inhibits migration and invasion of esophageal cancer cells by activating the mesenchymal‑epithelial transition process XIA CHEN1,2, BIN LU2,3, QIAN MA2, CHENG-DONG JI4 and JIAN-ZHONG LI3 1Key Laboratory, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090; 2International Joint Cancer Institute; 3Department of Biochemical Pharmacy, Second Military Medical University, Shanghai 200433; 4Department of Scientific Research Management, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, P.R. China Received June 13, 2018; Accepted November 2, 2018 DOI: 10.3892/ijo.2018.4639 Abstract. Eph receptor tyrosine kinases are critical for cell-cell Introduction communication during normal and oncogenic development. Eph receptor A3 (EphA3) expression is associated with Esophageal cancer is the eighth most prevalent type of tumor promotion in certain types of cancer; however, it acts cancer worldwide (1,2), of which, esophageal squamous cell as a tumor suppressor in others. The expression levels of carcinoma (ESCC) is a predominant histological type (3). EphA3 and its effects on tumor progression in esophageal Despite advances in diagnostic tools, surgical techniques and squamous cell carcinoma (ESCC) cell lines were determined chemotherapy over the past few decades, the 5-year survival using reverse transcription-quantitative polymerase chain rate for patients with esophageal cancer ranges between reaction analysis and a Transwell invasion assay. The present 15 and 20% (4). Therefore, novel diagnostic tools, therapeutic study demonstrated that EphA3 expression was decreased strategies and molecular prognostic markers are urgently in ESCC tissues and cell lines. Treatment with the DNA required for this disease.
    [Show full text]
  • Pancancer Progression Human Vjune2017
    Gene Symbol Accession Alias/Prev Symbol Official Full Name AAMP NM_001087.3 - angio-associated, migratory cell protein ABI3BP NM_015429.3 NESHBP|TARSH ABI family, member 3 (NESH) binding protein ACHE NM_000665.3 ACEE|ARACHE|N-ACHE|YT acetylcholinesterase ACTG2 NM_001615.3 ACT|ACTA3|ACTE|ACTL3|ACTSG actin, gamma 2, smooth muscle, enteric ACVR1 NM_001105.2 ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI activin A receptor, type I ACVR1C NM_145259.2 ACVRLK7|ALK7 activin A receptor, type IC ACVRL1 NM_000020.1 ACVRLK1|ALK-1|ALK1|HHT|HHT2|ORW2|SKR3|TSR-I activin A receptor type II-like 1 ADAM15 NM_207195.1 MDC15 ADAM metallopeptidase domain 15 ADAM17 NM_003183.4 ADAM18|CD156B|CSVP|NISBD|TACE ADAM metallopeptidase domain 17 ADAM28 NM_014265.4 ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII ADAM metallopeptidase domain 28 ADAM8 NM_001109.4 CD156|MS2 ADAM metallopeptidase domain 8 ADAM9 NM_001005845.1 CORD9|MCMP|MDC9|Mltng ADAM metallopeptidase domain 9 ADAMTS1 NM_006988.3 C3-C5|METH1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 ADAMTS12 NM_030955.2 PRO4389 ADAM metallopeptidase with thrombospondin type 1 motif, 12 ADAMTS8 NM_007037.4 ADAM-TS8|METH2 ADAM metallopeptidase with thrombospondin type 1 motif, 8 ADAP1 NM_006869.2 CENTA1|GCS1L|p42IP4 ArfGAP with dual PH domains 1 ADD1 NM_001119.4 ADDA adducin 1 (alpha) ADM2 NM_001253845.1 AM2|dJ579N16.4 adrenomedullin 2 ADRA2B NM_000682.4 ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR adrenoceptor alpha 2B AEBP1 NM_001129.3 ACLP AE binding protein 1 AGGF1 NM_018046.3 GPATC7|GPATCH7|HSU84971|HUS84971|VG5Q
    [Show full text]
  • Structural and Functional Insights Into the Transmembrane Domain Association of Eph Receptors
    International Journal of Molecular Sciences Review Structural and Functional Insights into the Transmembrane Domain Association of Eph Receptors Amita R. Sahoo 1 and Matthias Buck 1,2,3,4,* 1 Department of Physiology and Biophysics, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA; [email protected] 2 Department of Neurosciences, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA 3 Department of Pharmacology, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA 4 Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA * Correspondence: [email protected] Abstract: Eph receptors are the largest family of receptor tyrosine kinases and by interactions with ephrin ligands mediate a myriad of processes from embryonic development to adult tissue homeostasis. The interaction of Eph receptors, especially at their transmembrane (TM) domains is key to understanding their mechanism of signal transduction across cellular membranes. We review the structural and functional aspects of EphA1/A2 association and the techniques used to investigate their TM domains: NMR, molecular modelling/dynamics simulations and fluorescence. We also introduce transmembrane peptides, which can be used to alter Eph receptor signaling and we provide a perspective for future studies. Citation: Sahoo, A.R.; Buck, M. Keywords: receptor tyrosine kinase (RTKs); Eph receptors; TM dimerization; transmembrane Structural and Functional Insights domain (TMD) into the Transmembrane Domain Association of Eph Receptors. Int. J. Mol. Sci. 2021, 22, 8593. https:// doi.org/10.3390/ijms22168593 1. The Family of Eph Receptors, Their Domain Structure and Function Erythropoietin-producing hepatocellular carcinoma receptors (Ephs) represent the Academic Editors: Dimitar B.
    [Show full text]